| RS2545687862 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545688229 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545689085 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2545689094 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545689154 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545689194 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545689300 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545694414 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545694520 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545694567 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS2545698654 |
CDC20
|
Health Risk |
Pathogenic |
Oocyte maturation defect 14, Oocyte maturation defect 14 |
| RS2545698940 |
CDC20
|
Health Risk |
Pathogenic |
Oocyte maturation defect 14, Oocyte maturation defect 14 |
| RS2545699267 |
CDC20
|
Health Risk |
Pathogenic |
Oocyte maturation defect 14, Oocyte maturation defect 14 |
| RS2545699853 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS25457 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2545700340 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545709621 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545712483 |
OBSCN
|
Health Risk |
Likely pathogenic |
OBSCN-related disorder, OBSCN-related disorder |
| RS2545717131 |
TLK2
|
Health Risk |
Likely pathogenic |
Rare genetic intellectual disability, Rare genetic intellectual disability |
| RS2545718479 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545720528 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545721960 |
ITGB4
|
Health Risk |
Likely pathogenic |
— |
| RS2545722019 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545722634 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545728179 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2545730946 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545731855 |
ITGB4
|
Health Risk |
Likely pathogenic |
— |
| RS2545734366 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545737322 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545739504 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545740842 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2545741027 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545741796 |
CRYBA1
|
Health Risk |
Likely pathogenic |
Cataract 10 multiple types, Cataract 10 multiple types |
| RS2545746006 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545747164 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545749649 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545752835 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545752931 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Distal myopathy with anterior tibial onset |
| RS2545753088 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545753136 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545753329 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545753525 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545753602 |
DYSF
|
Health Risk |
Likely pathogenic |
— |
| RS2545754011 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545754867 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545755076 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545755689 |
LRP2
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS2545755699 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545755749 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545755925 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545757536 |
ZBTB11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 69 |
| RS2545765192 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545765366 |
OBSCN
|
Health Risk |
Likely pathogenic |
— |
| RS2545765625 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545768865 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545769842 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545770353 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545770831 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS2545776365 |
SPEG
|
Health Risk |
Likely pathogenic |
— |
| RS2545778305 |
TLK2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545779233 |
TLK2
|
Health Risk |
Likely pathogenic |
Developmental disorder, Developmental disorder |
| RS2545779418 |
ZBTB11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 69 |
| RS2545786054 |
ITGB4
|
Health Risk |
Likely pathogenic |
Lung cancer, Lung cancer |
| RS2545793597 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545794648 |
LRP2
|
Health Risk |
Pathogenic |
Hearing impairment, Hearing impairment |
| RS2545794997 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545798028 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2545798157 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Distal myopathy with anterior tibial onset |
| RS2545798522 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545799936 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545800105 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545800359 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal myopathy with anterior tibial onset, Miyoshi muscular dystrophy 1 |
| RS2545800574 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545800994 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545801210 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545801238 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS2545802033 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545802225 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545802550 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545802944 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545803481 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545804789 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545805164 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545805187 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545805212 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545807345 |
LRP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545809134 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545814877 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Distal myopathy with anterior tibial onset |
| RS2545814922 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545814988 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545815059 |
SZT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545815337 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545815498 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545815673 |
COL13A1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS2545816515 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545819541 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545819980 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545820139 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545820987 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545821718 |
LRP2
|
Health Risk |
Pathogenic |
— |